OncoCyte 10K 2020 Annual report | OCX Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. senior Avg

New words: AACR, accrual, advent, ALK, allotted, amid, amortizable, analyst, ASCO, assembled, atezolizumab, attended, attitude, automation, ballot, Biden, Biomedical, Biotech, breakthrough, bribery, Burning, Century, characteristic, charitable, choice, Chronix, CNI, coast, codify, commending, compatible, compelling, compliment, complimentary, complimenting, concrete, configuration, constitutionality, constrained, constraint, consummated, consummation, context, contributory, Conversion, counselor, COVID, CPRA, cybersecurity, debarment, decommission, deep, deeper, deferral, Delaware, Delinquent, deliverable, depicted, deploy, deployment, desert, DetermaCNI, DetermaMx, DetermaTx, devise, disorder, dissenter, distance, distraction, diversify, DTL, durable, dying, Eastern, effector, EGFR, EHR, element, endpoint, enriched, enrichment, enterprise, environmental, EPS, equityholder, ESMO, evade, evasion, evidenced, evolution, exacerbation, Excellence, exhausted, exploit, extracellular, figure, finder, flexibly, footprint, forecast, forecasted, forgiven, formula, freestanding, German, Germany, Gottingen, grew, hardware, Hot, hybrid, IASCLC, ICI, IHC, Illumina, illustrated, immunohistochemistry, inflammatory, intensity, intercompany, internationally, interplay, intervention, invading, invoke, ix, journey, justify, KeytrudaTM, KOL, labor, landscape, latent, leasehold, lender, living, load, logistical, LP, Macau, mechanism, menu, microenvironment, mixture, mode, modernize, modest, modestly, mother, MPEEM, NA, NASDAQ, neoadjuvant, nivolumab, nonfinancial, North, novelty, nurse, oncologist, OpdivoTM, outlined, overturn, overwhelm, Paperwork, Paycheck, pembrolizumab, perception, permissible, physiological, platinum, playing, poised, PPP, PRC, predetermined, preferential, printed, prison, procurement, progression, proximity, punished, quell, reassessed, reassessment, receptor, reissuance, relaxed, relief, remanded, remotely, repressive, rescind, rescinded, resistance, resistant, restaurant, resurgence, retention, RNAseq, Rock, round, rulemaking, SBA, scale, scenario, sense, shed, shorten, shrinkage, signature, simply, site, social, solution, SOW, spectrum, stimulated, strain, strived, stromal, strongly, sublicensee, subsuming, subtracted, surge, Taiwan, TecentriqTM, technique, teststhat, TheraSure, timeline, TM, transport, UCSF, unaffiliated, unaudited, unclear, uncollectible, uncompleted, unethical, unexpected, unmanaged, unmodified, unsupervised, upcoming, upfront, variation, vi, vii, viii, watchdog, west, wholly, widespread, wound

Removed: affiliate, affiliated, age, Anatomy, arrange, biopsied, blinded, capita, chest, CHIP, claw, coinsurance, collecting, Congressional, corrective, deadline, define, DetermaVu, DHS, diligence, diligent, discomfort, dissolve, enact, enforceability, enroll, equally, excise, excluding, faculty, fiduciary, focusing, footnote, fractionated, fulfill, hoped, improved, incentivize, incidentally, indeterminate, institution, instrumentation, intent, invasive, investor, involuntary, July, Korea, MACRA, majeure, malignancy, malignant, minimally, misconduct, moratorium, negligence, objective, passage, placement, prefer, procedure, provisional, Reauthorization, recommend, recoup, repeal, representation, restored, restrict, retail, revoke, risky, scan, science, sensitivity, setting, smoking, spending, sublicensing, suite, thereof, undergo, unnecessary, updated, Vice, voiced, warranty, Wistar

Subsidiary		State or Jurisdiction of Incorporation
Insight Genetics, Inc.		Tennessee
Razor Genomics, Inc.		Delaware

OncoCyte (OCX) 10-K2020 FY Annual report

Content analysis